Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
180 Life Sciences Corp. (ATNF) had Consolidated Net Income/Loss of $-2.37M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-2.37M |
|
-- |
|
-- |
|
$2.37M |
|
$-2.37M |
|
$0.00M |
|
$-2.37M |
|
$-2.37M |
|
$-2.37M |
|
$-2.37M |
|
|
Consolidated Net Income/Loss |
$-2.37M |
$-2.37M |
|
$-2.37M |
|
$-2.37M |
|
3.54M |
|
3.54M |
|
$-0.67 |
|
$-0.67 |
|
| Balance Sheet Financials | |
$4.03M |
|
-- |
|
$7.62M |
|
$11.65M |
|
$3.94M |
|
$0.00M |
|
$0.00M |
|
$3.95M |
|
$7.71M |
|
$0.08M |
|
$7.71M |
|
5.19M |
|
| Cash Flow Statement Financials | |
$-0.85M |
|
-- |
|
$-0.00M |
|
$4.59M |
|
$3.72M |
|
$-0.86M |
|
$0.57M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.02 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.85M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-30.75% |
|
-2836.35% |
|
-20.34% |
|
-30.73% |
|
$1.49 |
|
$-0.24 |
|
$-0.24 |
|